IFNG and cervical squamous intraepithelial neoplasia: In our previous clinical trial, we collected CxLs from patients with CIN and measured the number of IFNγ-producing cells using the ELISPOT assay to investigate the E7-specific Th1-type immune response in local cervical lesions [15].